NCT04700111Active, not recruitingNot Applicable
Lag of Accommodation With DOT Spectacle Lenses
SightGlass Vision, Inc.2 sites in 1 country30 target enrollmentStarted: February 1, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- SightGlass Vision, Inc.
- Enrollment
- 30
- Locations
- 2
- Primary Endpoint
- Best vision sphere
Study Overview
Brief Summary
The objective of the study is to measure the difference in the lag of accommodation between DOT spectacle lenses and control spectacles.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Treatment
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 6 Years to 18 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Best vision sphere
Time Frame: 90 minutes
1\) Autorefractor spherical equivalent refraction measured at distance and at 40cm with each pair of treatment spectacles
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Active, not recruiting
Not Applicable
Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal ThicknessMyopia ProgressionJuvenile MyopiaMyopiaNCT05617794SightGlass Vision, Inc.30
Completed
Not Applicable
RxSight Light Adjustable Lens and Light Delivery Device New Enrollment StudyCataractAphakiaNCT05202808RxSight, Inc.500
Completed
Not Applicable
An Open-Label Evaluation of Degree of Accommodation in Pseudophakic Patients Bilaterally Implanted With Monofocal Intraocular LensesPseudophakiaNCT01004549Innovative Medical30
Completed
Not Applicable
Ocular Comfort and OCT Observation of Post Lens Clearance and Ocular Tissue CompressionOcular ComfortNCT01423773CIBA VISION20
Completed
Not Applicable
Clinical Comparison of DDT2 Contact Lens and a Daily Disposable Contact Lens - Study 1MyopiaRefractive ErrorNCT03888469Alcon Research92
